1. Home
  2. GBIO vs FLUX Comparison

GBIO vs FLUX Comparison

Compare GBIO & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • FLUX
  • Stock Information
  • Founded
  • GBIO 2016
  • FLUX N/A
  • Country
  • GBIO United States
  • FLUX United States
  • Employees
  • GBIO N/A
  • FLUX N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • FLUX Industrial Machinery/Components
  • Sector
  • GBIO Health Care
  • FLUX Miscellaneous
  • Exchange
  • GBIO Nasdaq
  • FLUX Nasdaq
  • Market Cap
  • GBIO 29.2M
  • FLUX 25.4M
  • IPO Year
  • GBIO 2020
  • FLUX N/A
  • Fundamental
  • Price
  • GBIO $0.43
  • FLUX $1.88
  • Analyst Decision
  • GBIO Strong Buy
  • FLUX Strong Buy
  • Analyst Count
  • GBIO 4
  • FLUX 2
  • Target Price
  • GBIO $7.33
  • FLUX $6.00
  • AVG Volume (30 Days)
  • GBIO 1.2M
  • FLUX 135.9K
  • Earning Date
  • GBIO 08-06-2025
  • FLUX 08-15-2025
  • Dividend Yield
  • GBIO N/A
  • FLUX N/A
  • EPS Growth
  • GBIO N/A
  • FLUX N/A
  • EPS
  • GBIO N/A
  • FLUX N/A
  • Revenue
  • GBIO $24,556,000.00
  • FLUX $63,074,000.00
  • Revenue This Year
  • GBIO N/A
  • FLUX $11.10
  • Revenue Next Year
  • GBIO N/A
  • FLUX $12.66
  • P/E Ratio
  • GBIO N/A
  • FLUX N/A
  • Revenue Growth
  • GBIO 146.47
  • FLUX N/A
  • 52 Week Low
  • GBIO $0.30
  • FLUX $1.15
  • 52 Week High
  • GBIO $3.65
  • FLUX $4.75
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 60.24
  • FLUX 52.47
  • Support Level
  • GBIO $0.32
  • FLUX $1.80
  • Resistance Level
  • GBIO $0.36
  • FLUX $2.53
  • Average True Range (ATR)
  • GBIO 0.03
  • FLUX 0.20
  • MACD
  • GBIO 0.01
  • FLUX 0.02
  • Stochastic Oscillator
  • GBIO 78.75
  • FLUX 35.19

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

Share on Social Networks: